AptarGroup, Inc. (ATR) has a MoatMap StockRank of 74/100 based on Quality (64/100), Value (49/100), and Momentum (43/100) factor scores. The current signal is BUY. AptarGroup, as a provider of specialized drug delivery and consumer dispensing systems, exhibits 'Durable Quality & Moats' through its essential, high-value-added products and intellectual property, enabling it to maintain pricing power and consistent demand even in a turbulent economic environment, positioning it as a quality compounder.
AptarGroup designs and manufactures innovative dispensing, sealing, and active packaging solutions for beauty, personal care, pharma, and food & beverage markets. It benefits from extensive intellectual property, advanced manufacturing capabilities, and long-standing relationships with leading global brands. The company is a global leader in value-added dispensing and active packaging, serving critical functions from product preservation to precise drug delivery.
| Price | $115.30 |
| Market Cap | $7.4B |
| P/E (TTM) | 19.93 |
| P/E (Forward) | 18.55 |
| Price/Book | 2.83 |
| Return on Equity | 14.8% |
| Return on Invested Capital | 13.3% |
| Debt/Equity | 53.72 |
| Gross Margin | 36.7% |
| Operating Margin | 11.1% |
| Revenue Growth | 10.8% |
| Dividend Yield | 1.6% |
| Free Cash Flow | $253M |
AptarGroup, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).